⚠ Evidence note: Most trends in this area rest on anecdote and mechanism; where real evidence exists it is usually for narrower claims than the trend makes.
Red-Light and Near-Infrared Photobiomodulation
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-29 — Low-power infrared laser on telomere maintenance in an experimental model of arthritis.: Zymosan-induced mouse arthritis study: low-power infrared laser PBM altered temporal expression of shelterin/telomere-maintenance genes (TRF1, TRF2, POT1, TIN2) in a time- and fluence-dependent manner, with high-fluence treatment upregulating TRF2, POT1, and TIN2 at 72h — extends mechanistic PBM claims from anti-inflammation toward telomere/genomic-stability biology, mouse-only. [animal-model] (novelty: 3)
- 2026-09-21 — The Revitalize Study in Older Adults at Risk for Alzheimer’s Disease: Revitalize Phase II multi-site sham-controlled RCT protocol registered: 12 weeks of combined transcranial + intranasal NIR photobiomodulation in older adults at elevated Alzheimer’s risk, with cognition, 31P-MRS ATP mitochondrial markers, and resting-state connectivity as endpoints — protocol only, no efficacy readout yet. [human-rct] (novelty: 3)
- 2026-06-16 — Using Light Therapy for Mild Cognitive Impairment: Registered 12-week sham-controlled RCT protocol testing daily 20-min transcranial NIR photobiomodulation in MCI for cognition, neurovascular coupling, and inflammation/oxidative-stress markers — protocol only, no readout yet. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Low-power infrared laser on telomere maintenance in an experimental model of arthritis.
29-sep-2026
novelty 3
per-area 3
strengthens
The Revitalize Study in Older Adults at Risk for Alzheimer's Disease
21-sep-2026
novelty 3
per-area 3
strengthens
Pilot Intervention With Near Infrared Stimulation
05-aug-2026
novelty 2
per-area 2
strengthens
Using Light Therapy for Mild Cognitive Impairment
16-jun-2026
novelty 3
per-area 3
strengthens